Showing results (201-210 of 333) with videos related to

Sort By:
Pageof 34
Future Oncology (London, England)|September 25, 2025
RELAY: safety and efficacy of ramucirumab plus erlotinib in elderly Japanese patients with metastatic <i>EGFR</i>-mutated NSCLCKazumi Nishino, Takashi Seto, Makoto Nishio, et al.
Molecules (Basel, Switzerland)|August 30, 2019
Kurarinone from <i>Sophora Flavescens</i> Roots Triggers ATF4 Activation and Cytostatic Effects Through PERK PhosphorylationSakiko Nishikawa, Yuka Itoh, Muneshige Tokugawa, et al.
Molecular and Cellular Biology|August 2, 2006
CCAAT/enhancer-binding protein homologous protein (CHOP) regulates osteoblast differentiationKen Shirakawa, Shingo Maeda, Tomomi Gotoh, et al.
Investigational New Drugs|November 4, 2022
Oral formulation of bendamustine hydrochloride for patients with advanced solid tumors; a phase 1 studyToshio Shimizu, Kazuhiko Nakagawa, Hidetoshi Hayashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 21, 2022
Progression from early to advanced stage of immune-related cholangitisSatoru Hagiwara, Takeshi Yoshida, Naoshi Nishida, et al.
Molecular Cancer Therapeutics|May 22, 2016
Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic HER4 Mutations in HNSCCYu Nakamura, Yosuke Togashi, Hirokazu Nakahara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2016
Functional Analyses of Mutations in Receptor Tyrosine Kinase Genes in Non-Small Cell Lung Cancer: Double-Edged Sword of DDR2Masato Terashima, Yosuke Togashi, Katsuaki Sato, et al.
The Oncologist|September 12, 2020
Phase I/II Study of Cisplatin plus Nab-Paclitaxel with Concurrent Thoracic Radiotherapy for Patients with Locally Advanced Non-Small Cell Lung CancerHidetoshi Hayashi, Masakazu Ogura, Takashi Niwa, et al.
Journal of Biochemistry|November 10, 2023
Involvement of cardiac glycosides targeting Na/K-ATPase in their inhibitory effects on c-Myc expression via its transcription, translation and proteasomal degradationMuneshige Tokugawa, Yasumichi Inoue, Hiromasa Aoki, et al.
Clinical Lung Cancer|May 9, 2020
Treatment Rationale and Design for APPLE (WJOG11218L): A Multicenter, Open-Label, Randomized Phase 3 Study of Atezolizumab and Platinum/Pemetrexed With or Without Bevacizumab for Patients With Advanced Nonsquamous Non-Small-Cell Lung CancerYoshimasa Shiraishi, Junji Kishimoto, Kentaro Tanaka, et al.
Pageof 34